title: An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia.
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Nakajima
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Uchida
authors.forename: Takefumi
authors.initials: T
authors.lastname: Suzuki
authors.forename: Masayuki
authors.initials: M
authors.lastname: Tomita
authors.forename: Kenichi
authors.initials: K
authors.lastname: Tsunoda
authors.forename: Masaya
authors.initials: M
authors.lastname: Kitta
authors.forename: Hiroyoshi
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Kensuke
authors.initials: K
authors.lastname: Nomura
authors.forename: Koichiro
authors.initials: K
authors.lastname: Watanabe
authors.forename: Haruo
authors.initials: H
authors.lastname: Kashima
mesh_terms: D000328:Adult; D000368:Aged; D001569:Benzodiazepines / Q000009:adverse effects*; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D006993:Hypnotics and Sedatives; D001569:Benzodiazepines